Franklin Biolabs

Franklin Biolabs Founder & Executive Chair and GEMMA Biotherapeutics Founder, President, & CEO James M. Wilson, MD, PhD spoke at the #STATBreakthrough Summit yesterday. #genetherapy #raredisease #biotech

Franklin Biolabs Founder and Executive Chair and GEMMA Biotherapeutics Founder, President, and CEO James M. Wilson, MD, PhD will discuss the future of gene therapy at #STATBreakthrough East on Thursday morning, March 20! https://lnkd.in/g9xXZP7K #GeneTherapy #RareDisease #biotech

Franklin Biolabs will have a presence at Society of Toxicology (SOT) in Orlando, March 16-20! Meet the Director of our Pharmacology & Toxicology Unit and learn more about how we can support your safety study. Please reach out to Gavin Gagnon or April Hall to connect with us at the conference. Check out the Franklin Biolabs website here: https://lnkd.in/eENXAnQZ #SOT2025 #CellAndGeneTherapy #PreclinicalResearch

On Rare Disease Day 2025, check out this Q&A by Drug Discovery World for insights from a range of industry experts, including James M. Wilson, MD, PhD from GEMMA Biotherapeutics. https://lnkd.in/eRAxQ8eP

Today is Rare Disease Day! Join GEMMA Biotherapeutics in recognizing the 300 million people worldwide living with a rare disease. Today, we wear stripes as the zebra is a powerful symbol for rare diseases. Historically, medical professionals were taught, “When you hear hoofbeats, think horses, not zebras”—a reminder to consider common diagnoses before rare ones. However, we now know that rare diseases are more prevalent than previously understood, affecting 1 in 10 Americans. By wearing stripes, you can show your solidarity and help raise awareness for the hundreds of millions of individuals who deserve our recognition and support. Be sure to visit www.rarediseaseday.org to learn how you can participate in Rare Disease Day activities, find helpful resources for educating others and spreading awareness, and ramp up your social media in honor of the rare community! #rarediseaseday #raredisease #rarediseaseadvocacy?

It’s Rare Disease Week! This week culminates with Rare Disease Day, on Friday 28th February, a global movement that aims to recognize the 300 million people worldwide who are living with a rare disease. We observe Rare Disease Day to champion equity in social opportunity, healthcare, and access to diagnosis and treatments for individuals living with a rare disease. This week, 600+ events will be held around the world to acknowledge, celebrate, and support those who are impacted, enabling progress and amplifying advocacy. This year’s Rare Disease Day theme is “More than You Can Imagine”, which shines a spotlight on coming together as a community in honor of rare diseases. Because together, we can do more than you can imagine. Watch the official RDD 2025 Video here - https://lnkd.in/dE56sfWf (1 min) More than 10,000 rare diseases affect over 300 million people worldwide, and only 5% have an FDA-approved treatment. Not one rare disease has an available “cure”. By recognizing Rare Disease Day on February 28th, we can help raise awareness and drive support for critical research and patient advocacy. Check out www.rarediseaseday.org for tons of resources to help you advocate for and support the rare disease community. #rarediseaseday #raredisease #rarediseaseadvocacy?

Check out this new feature on the Bioculture Group! It is entitled 'Caring for Life: Bioculture’s Journey from Biodiversity to Global Health Innovation.' https://lnkd.in/eDXeskYN

Congratulations to Franklin Biolabs Founder and Executive Chair, James M. Wilson, MD, PhD, who will be honored today with the PMWC - Precision Medicine World Conference 2025 Pioneer Award for Gene and Cell Therapies.?The award recognizes his groundbreaking work in viral vector-based gene therapies, significantly impacting the treatment of rare genetic diseases.?His keynote presentation is entitled 'The Promise of Genetic Medicines Unless You're Too Poor or Too Rare.' #PMWC25 #RareDiseases #GeneTherapy

Congratulations to Franklin Biolabs Founder and Executive Chair, James M. Wilson, MD, PhD, who will be honored today with the WORLDSymposium 2025 Roscoe O. Brady Award for outstanding innovation and accomplishment in the field of lysosomal disease research and therapy.?His award presentation is entitled Lysosomal Diseases: A paradigm for personalized medicine. #LysosomalDisease #RareDiseases #GeneTherapy

At Franklin Biolabs, we partner with clients to accelerate novel cell and gene therapy (CGT) assets from clinical candidate to IND in 18 months.?Our experienced team came from James M. Wilson, MD, PhD's academic program, a recognized leader in AAV-based genetic medicines and innovation supporting the global gene therapy industry with a proven track record of advancing discoveries to the clinic.?We leverage our deep bench-to-bedside expertise in preclinical/translational studies, vector production & CMC, and bioanalytical research to provide comprehensive CGT solutions including worldwide clinical development. Learn more at https://lnkd.in/eTB7_C8Y Speak to a scientist about your project: [email protected] #CellAndGeneTherapy #AAV #ContractResearchOrganization